| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Floxacillin (as floxacillin sodium) 500 mg powder for solution for infusion and/or injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely fosfomycin (as fosfomycin sodium) 4 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely fosfomycin (as fosfomycin sodium) 4 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Fosfomycin (as fosfomycin sodium) 4 g powder for solution for infusion and/or injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Fosfomycin (as fosfomycin sodium) 4 g powder for solution for infusion and/or injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Fosfomycin (as fosfomycin sodium) 2 g powder for solution for infusion vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Fosfomycin (as fosfomycin sodium) 2 g powder for solution for infusion vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely fosfomycin (as fosfomycin sodium) 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely fosfomycin (as fosfomycin sodium) 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Fosaprepitant (as fosaprepitant dimeglumine) 150 mg powder for solution for infusion vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Fosaprepitant (as fosaprepitant dimeglumine) 150 mg powder for solution for infusion vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely fosaprepitant (as fosaprepitant dimeglumine) 115 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely fosaprepitant (as fosaprepitant dimeglumine) 115 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Olanzapine 10 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Olanzapine 10 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely parecoxib (as parecoxib sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely parecoxib (as parecoxib sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrocortisone (as hydrocortisone sodium succinate) 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone (as hydrocortisone sodium succinate) 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydroxocobalamin 2.5 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely hydroxocobalamin 2.5 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Paclitaxel (as albumin bound paclitaxel) 100 mg powder for dispersion for infusion vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Paclitaxel (as albumin bound paclitaxel) 100 mg powder for dispersion for infusion vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely paclitaxel (as albumin bound paclitaxel) 250 milligram/1 vial powder for conventional release dispersion for infusion (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely paclitaxel (as albumin bound paclitaxel) 250 milligram/1 vial powder for conventional release dispersion for infusion (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Human fibrinogen 1 g powder for solution for infusion and/or injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Human fibrinogen 1 g powder for solution for infusion and/or injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheopulmonary instillation (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheopulmonary instillation (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Voriconazole 200 mg powder for solution for infusion vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Voriconazole 200 mg powder for solution for infusion vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely verteporfin 15 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely verteporfin 15 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely verteporfin 15 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely verteporfin 15 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely vancomycin (as vancomycin hydrochloride) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely vancomycin (as vancomycin hydrochloride) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely vancomycin (as vancomycin hydrochloride) 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely vancomycin (as vancomycin hydrochloride) 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Vancomycin (as vancomycin hydrochloride) 500 mg powder for solution for infusion vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Vancomycin (as vancomycin hydrochloride) 500 mg powder for solution for infusion vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Thyrotropin alfa 900 microgram powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Thyrotropin alfa 900 microgram powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely daptomycin 350 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely daptomycin 350 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Aztreonam 1 g powder for solution for infusion and/or injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Aztreonam 1 g powder for solution for infusion and/or injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely ceftaroline fosamil (as ceftaroline fosamil acetic acid solvate) 600 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely ceftaroline fosamil (as ceftaroline fosamil acetic acid solvate) 600 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Cefuroxime (as cefuroxime sodium) 750 mg powder for solution for infusion and/or injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Cefuroxime (as cefuroxime sodium) 750 mg powder for solution for infusion and/or injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Caspofungin (as caspofungin acetate) 50 mg powder for solution for infusion vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Caspofungin (as caspofungin acetate) 50 mg powder for solution for infusion vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely caspofungin (as caspofungin acetate) 70 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely caspofungin (as caspofungin acetate) 70 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely azacitidine 100 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely azacitidine 100 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely delafloxacin (as delafloxacin meglumine) 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely delafloxacin (as delafloxacin meglumine) 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Carmustine 100 mg powder for solution for infusion and/or injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Carmustine 100 mg powder for solution for infusion and/or injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Carmustine 100 mg powder for solution for infusion vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Carmustine 100 mg powder for solution for infusion vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely esomeprazole (as esomeprazole sodium) 40 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely esomeprazole (as esomeprazole sodium) 40 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely aztreonam (as aztreonam lysine) 75 milligram/1 vial powder for conventional release solution for inhalation (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely aztreonam (as aztreonam lysine) 75 milligram/1 vial powder for conventional release solution for inhalation (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| céfazoline 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| céfazoline 1 g, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| acyclovir 250 mg, fiole de poudre pour perfusion (médicament clinique) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| acyclovir 250 mg, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| amoxicilline 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| amoxicilline 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Agalsidase beta 5 mg powder for solution for injection vial |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| Agalsidase beta 5 mg powder for solution for injection vial |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| céfazoline 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| céfazoline 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| céfradine 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| céfradine 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| céfradine 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| céfradine 1 g, pour injection (poudre pour reconstitution) (médicament clinique) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| amphotéricine 50 mg, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| amphotéricine 50 mg, fiole de poudre pour perfusion (médicament clinique) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| acyclovir 500 mg, fiole de poudre pour perfusion (médicament clinique) |
Has presentation strength denominator unit (attribute) |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
1 |
| acyclovir 500 mg, fiole de poudre pour perfusion (médicament clinique) |
Has unit of presentation |
True |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
FHIR